These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8744551)

  • 1. Evaluation of the safety of two attenuated oral rabies vaccines, SAG1 and SAG2, in six Arctic mammals.
    Follmann EH; Ritter DG; Baer GM
    Vaccine; 1996 Mar; 14(4):270-3. PubMed ID: 8744551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of lyophilized SAG2 oral rabies vaccine in collared lemmings.
    Follmann EH; Ritter DG; Hartbauer DW
    J Wildl Dis; 2002 Jan; 38(1):216-8. PubMed ID: 11838220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe.
    Masson E; Cliquet F; Aubert M; Barrat J; Aubert A; Artois M; Schumacher CL
    Vaccine; 1996 Nov; 14(16):1506-10. PubMed ID: 9014291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis).
    Rupprecht CE; Charlton KM; Artois M; Casey GA; Webster WA; Campbell JB; Lawson KF; Schneider LG
    J Wildl Dis; 1990 Jan; 26(1):99-102. PubMed ID: 2304207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety evaluation of the SAG2 rabies virus mutant in Tunisian dogs and several non-target species.
    Hammami S; Schumacher CL; Cliquet F; Barrat J; Tlatli A; Ben Osman R; Aouina T; Aubert A; Aubert M
    Vet Res; 1999; 30(4):353-62. PubMed ID: 10478416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species.
    Vos A; Neubert A; Aylan O; Schuster P; Pommerening E; Müller T; Chivatsi DC
    Epidemiol Infect; 1999 Aug; 123(1):165-75. PubMed ID: 10487653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenicity of oral rabies vaccine residues].
    Ross RS; Roggendorf M
    Dtsch Med Wochenschr; 1998 Feb; 123(9):271. PubMed ID: 9524541
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species.
    Brochier B; Blancou J; Thomas I; Languet B; Artois M; Kieny MP; Lecocq JP; Costy F; Desmettre P; Chappuis G
    J Wildl Dis; 1989 Oct; 25(4):540-7. PubMed ID: 2681844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vaccination of captive arctic foxes with lyophilized SAG2 rabies vaccine.
    Follmann EH; Ritter DG; Donald WH
    J Wildl Dis; 2004 Apr; 40(2):328-34. PubMed ID: 15362836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAG-2 oral rabies vaccine.
    Schumacher CL; Coulon P; Lafay F; Bénéjean J; Aubert MF; Barrat J; Aubert A; Flamand A
    Onderstepoort J Vet Res; 1993 Dec; 60(4):459-62. PubMed ID: 7777336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral rabies vaccine: evaluation of its infectivity in three species of rodents.
    Winkler WG; Shaddock JH; Williams LW
    Am J Epidemiol; 1976 Sep; 104(3):294-8. PubMed ID: 961696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral rabies vaccination of arctic foxes (Alopex lagopus) with an attenuated vaccine.
    Follmann EH; Ritter DG; Baer GM
    Vaccine; 1992; 10(5):305-8. PubMed ID: 1574916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
    Cliquet F; Robardet E; Picard Meyer E
    Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of SAG1 oral vaccine for the long-term protection of red foxes (Vulpes vulpes) against rabies.
    Artois M; Cliquet F; Barrat J; Schumacher CL
    Vet Rec; 1997 Jan; 140(3):57-9. PubMed ID: 9023904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy.
    Nakagawa K; Ito N; Masatani T; Abe M; Yamaoka S; Ito Y; Okadera K; Sugiyama M
    Vaccine; 2012 May; 30(24):3610-7. PubMed ID: 22464967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus).
    Bingham J; Foggin CM; Gerber H; Hill FW; Kappeler A; King AA; Perry BD; Wandeler AI
    Vet Rec; 1992 Jul; 131(3):55-6. PubMed ID: 1441164
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
    Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
    Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs.
    Fekadu M; Nesby SL; Shaddock JH; Schumacher CL; Linhart SB; Sanderlin DW
    Vaccine; 1996 Apr; 14(6):465-8. PubMed ID: 8782341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs.
    Cliquet F; Gurbuxani JP; Pradhan HK; Pattnaik B; Patil SS; Regnault A; Begouen H; Guiot AL; Sood R; Mahl P; Singh R; Meslin FX; Picard E; Aubert MF; Barrat J
    Vaccine; 2007 Apr; 25(17):3409-18. PubMed ID: 17224221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife.
    Artois M; Charlton KM; Tolson ND; Casey GA; Knowles MK; Campbell JB
    Can J Vet Res; 1990 Oct; 54(4):504-7. PubMed ID: 2249183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.